Renovacor

Closed (deSPAC)

Profile in progress

What it is: Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases
What it’s doing now: Merging with Chardan Healthcare Acquisition 2 Corp. (CHAQ) — closed (despac).
What you should know: The deal carries a $85M minimum-cash condition — heavy redemptions can break it.

The business, per its filings

SEC primary

Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. The company’s lead program in BAG3-associated dilated cardiomyopathy (DCM) uses gene transfer technology to address the monogenic cause of this severe form of heart failure. Renovacor’s vision is to bring life-changing therapies to patients living with serious genetic cardiovascular and related diseases, by developing medicines that target the underlying cause of disease and provide a transformative benefit and significant improvement to quality of life.

What the company says about itself

Web research — not audited

What our web check found

[WEB-INTEL 2026-08-26] 6 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Deal Size, $M $197.80M" [https://www.spacresearch.com/symbol/CHAQ.U] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Closing Date Sep 2, 2021" [https://www.spacresearch.com/symbol/CHAQ.U] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Renovacor said Aug. 14 that it raised $11 million in a Series A co-led by Novartis Venture Fund, Broadview Ventures, and BioAdvance, and joined ..." [https://www.venturecapitaljournal.com/renovacor-raises-11-mln/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Most recently, it raised $11.0M Series A in August 2019." [https://startupintros.com/orgs/renovacor] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The last funding was announced in September 2021." [https://www.vcbacked.co/company/renovacor] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "December 1, 2022, Renovacor shares ceased to trade" [https://biopharmaapac.com/news/41/2263/rocket-pharmaceuticals-completes-acquisition-of-renovacor.html] [WEB-INTEL 2026-08-26] 5 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Deal Size, $M $197.80M" [https://www.spacresearch.com/symbol/CHAQ.U] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Closing Date Sep 2, 2021" [https://www.spacresearch.com/symbol/CHAQ.U] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Renovacor said Aug. 14 that it raised $11 million in a Series A co-led by Novartis Venture Fund, Broadview Ventures, and BioAdvance, and joined ..." [https://www.venturecapitaljournal.com/renovacor-raises-11-mln/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Most recently, it raised $11.0M Series A in August 2019." [https://startupintros.com/orgs/renovacor] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The last funding was announced in September 2021." [https://www.vcbacked.co/company/renovacor]

Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Renovacor is merging with Chardan Healthcare Acquisition 2 Corp. (CHAQ) currently marked Closed (deSPAC).

Headline equity value	—
Minimum cash to close	$85M

Structure per SEC accession(s) 0001193125-21-236673, 0001140361-22-039152. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Renovacor going public?

Renovacor has an approved merger with the SPAC Chardan Healthcare Acquisition 2 Corp. (CHAQ). Deal status: Closed (deSPAC).

Does Renovacor have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.